Introducing the new AltIndexLearn more
Gyre Therapeutics

Gyre Therapeutics (GYRE) Earnings Prediction

Updated August 11, 2026 · AltIndex alt-data view going into the print

AltIndex AI Score on Gyre Therapeutics is 48 — signals are mixed heading into the print. Underlying trend: 2 tracked signals showing mixed direction over the last 3 months.

Next report
Thursday, November 5, 2026
EPS Estimate
$0.08
AltIndex AI Score
48
AI Prediction
Mixed signals

GYRE stock price — last 3 months

Gyre Therapeutics (GYRE) is trading at $6.64, down 8.8% over the last 3 months (from $7.28 three months ago).

What the alt-data signals say about Gyre Therapeutics right now

Trends across the last 3 months — the run-up to Gyre Therapeutics’s next earnings print.

Signal Current 3-month change
Job postings 1 No 3-month baseline
LinkedIn headcount 17 ↑ +21.4%
Web traffic 3,515 ↓ -49.5%

Full daily-resolution trend charts on every signal are on the GYRE ticker page.

Get alerted when GYRE signals inflect

AltIndex stock alerts fire when alt-data on GYRE breaks out — web traffic spike, hiring surge, sentiment shift — often days before the earnings number confirms it.

Sign up to AltIndex →

Gyre Therapeutics earnings: frequently asked questions

When does Gyre Therapeutics report earnings next?
Gyre Therapeutics (GYRE) is scheduled to report next earnings on Thursday, November 5, 2026. The exact pre-market or post-market time is set by the company a few days ahead; see the official investor-relations page for confirmation.
What does the AltIndex AI Score say about Gyre Therapeutics going into earnings?
Current AI Score on Gyre Therapeutics: 48 — Mixed signals. The AI Score combines 10,000+ alternative-data and financial signals into one 0–100 number; higher = signals lean bullish, lower = signals lean bearish. Full per-signal breakdown is on the GYRE ticker page.
What is the EPS estimate for Gyre Therapeutics?
Analyst consensus EPS estimate for Gyre Therapeutics’s next quarter: $0.08. We refresh this from analyst-estimate data daily.
How accurate are AltIndex’s earnings predictions for Gyre Therapeutics?
AltIndex doesn’t predict the exact EPS number — the alt-data signals don’t see the financials. What the signals can do is tell you whether the underlying business momentum (web traffic, hiring, social audience, sentiment) supports the analyst consensus or contradicts it. AltIndex publishes the full pick history at altindex.com/results — including the misses — so you can verify how the signal-driven calls have performed.
Where can I see the full signal breakdown on Gyre Therapeutics?
Visit https://altindex.com/ticker/gyre for the complete per-signal view: AI Score history, web traffic trend chart, 8-platform social audience tracking, hiring activity, news mention volume, sentiment scoring, insider trades and Congressional disclosures.
How can I get alerted before Gyre Therapeutics reports earnings?
AltIndex stock alerts fire when alt-data signals on a stock break out of their historical range — often days or weeks before the earnings number confirms it. Add GYRE to your watchlist and you’ll get notified when its signals shift. See altindex.com/stock-alerts for the full alert categories.

See every alt-data signal on GYRE

Sign up to see the full daily-resolution trend charts on every signal AltIndex tracks for Gyre Therapeutics — web traffic, hiring, 8-platform social audience, sentiment, insider trades and the full AI Score breakdown.

Sign up to AltIndex → Log in